ACE Technology Guidances communicate recommendations from the MOH Drug Advisory Committee or the MOH Medical Technology Advisory Committee on the funding status and appropriate use of drugs, vaccines or medical technologies that have been evaluated by ACE. The guidances also include the Committee’s rationale for the funding recommendations, and key clinical and economic evidence which informed their deliberations. Plain English Summaries (PES) to explain ACE Technology Guidances are available for patients and the public.

Published on 01 Oct 2018
Last Updated on 01 Oct 2018
A- A+
Guidance Recommendations
The Ministry of Health’s Drug Advisory Committee has not recommended listing paliperidone or aripiprazole injections on the Medication Assistance Fund (MAF) for treating schizophrenia, due to unacceptable cost-effectiveness compared with first-generation antipsychotic injections at the prices proposed by the manufacturers.


SGA injections for schizophrenia (1 Oct 2018)